Skip to main content

Fortesta FDA Approval History

FDA Approved: Yes (First approved December 29, 2010)
Brand name: Fortesta
Generic name: testosterone
Dosage form: Gel
Company: Endo Pharmaceuticals
Treatment for: Hypogonadism, Male

Fortesta (testosterone) Gel is a topical androgen indicated for replacement therapy in male hypogonadism.

Development timeline for Fortesta

Dec 30, 2010Approval Endo Pharmaceuticals Receives FDA Approval for Fortesta (Testosterone) Gel as a Class III Product for Topical Use for Men With Low Testosterone
Jul  1, 2010Endo Pharmaceuticals Completes Next Step in Regulatory Process for Fortesta for Men With Low Testosterone
Oct 22, 2009Endo Pharmaceuticals Gives Update on Regulatory Status of Fortesta
Aug 26, 2009Endo Pharmaceuticals to Partner With ProStrakan to Commercialize Fortesta in the U.S.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.